Connection
Tatiana Kutateladze to Leukemia, Lymphocytic, Chronic, B-Cell
This is a "connection" page, showing publications Tatiana Kutateladze has written about Leukemia, Lymphocytic, Chronic, B-Cell.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.390 |
|
|
|
-
Smith AL, Pal D, Martinez-Rico R, Eiken AP, Durden DL, Kutateladze TG, El-Gamal D. Preclinical activity of a novel multi-axis inhibitor in aggressive and indolent B-cell malignancies. Leuk Lymphoma. 2023 12; 64(14):2333-2337.
Score: 0.204
-
Smith AL, Eiken AP, Skupa SA, Moore DY, Umeta LT, Smith LM, Lyden ER, D'Angelo CR, Kallam A, Vose JM, Kutateladze TG, El-Gamal D. A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia. Int J Mol Sci. 2022 Jun 16; 23(12).
Score: 0.187